Sorry if repeating something already said haven’t read entire thread. But don’t we have suggestive evidence that at its root ME is neither of the two?
That what is stated in OP are more downstream consequences and it’s immune mediated given that corticosteroids (not low dose) temporarily and effectively prevent PEM and the other symptoms for anyone who takes them? We just cannot take steroids as a solution for more than a few days for the well known reasons why they can’t be used as a treatment.
Chris Armstrong (2015), and Fluge and Mella* (2016), have both pointed to increased metabolism of amino acids [specifically amino acids that bypass PDH/pyruvate "blockage" in the citric acid cycle]. Chris Armstrong is now being funded by OMF to look at protein (nitrogen) metabolism.
Fluge and Mella* suggested a signalling factor was causing this change in metabolism. I have wondered whether switching to using tryptophan, with increased (toxic) intracellular concentrations, would produce some sort of threat response --- ME/CFS. As Robert Phair has pointed out, ME/CFS, is a stable condition (bi-stability) on the face of it aberrant signalling could maintain this pathological state [ME/CFS].
There's a bit of genetic evidence potentially implicating protein metabolism here**
It looks like GWAS*** is a potential way to make progress here --- funding for Chris Ponting's GWAS study has been approved.
Maybe lobby for funding via ME Action, Solve ---
*"According to this model, ME/CFS is caused by immune interference with an unidentified target, potentially a signaling factor, which ultimately causes metabolic dysfunction and induction of secondary rescue mechanisms."[
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161229/]
**"SLC25A15 encodes the Ornithine Transporter type 1 protein that transports ornithine (as well as lysine and arginine) across the inner membrane of mitochondria to the mitochondrial matrix. Ornithine is an amino acid that plays a role in the urea cycle. A person with the rs7337312 CFS risk allele is expected to produce lower amounts of SLC25A15 mRNA resulting in reduced transport of ornithine into the mitochondrion and higher amounts of ornithine in blood. Yamano et al. (44) and Naviaux et al. (14), but not Armstrong et al. (45), report some evidence in support of this prediction."[]
***"Genome-Wide Association Study A genome-wide association study (GWAS) is ideal for discovering genetic causes of disease and new biology particularly when disease aetiology is unknown, as is the case for ME/CFS."
https://watermark.silverchair.com/d...iCtIBnKX2vZuB46ERXeBkBit-7Zn63Co7uXs04QEUwyTM